1.
Curr Med Res Opin
; 5(1): 74-6, 1977.
Article
in English
| MEDLINE
| ID: mdl-334476
ABSTRACT
Preliminary results in 12 patients with rheumatoid arthritis are presented from an on-going double-blind, between patient comparison of flurbiprofen and phenylbutazone. Patients received either 300 mg flurbiprofen daily or 400 mg phenylbutazone daily over a 2-week treatment period. Two patients treated with phenylbutazone developed a rash, and treatment was discontinued in 1 of them after Day 2.